Underage Drinking, Alcohol Dependence, and Young People Starting to Use Prescription Pain Relievers Extra-medically: A Zero-inflated Poisson Regression Model

Overview

Journal Exp Clin Psychopharmacol

Publisher American Psychological Association

Specialty Pharmacology

Date 2018 Sep 29

PMID 30265064

Citations 2

Authors

Maria A Parker

James C Anthony

Affiliations

Soon will be listed here.

Abstract

Among young people who start using prescription pain relievers (PPRs) for feeling-states such as "to get high" or otherwise beyond boundaries intended by prescribers, the most recent epidemiological incidence estimates show 2%-9% with rapid-onset opioid dependence. In this work, we study recently active underage alcohol dependence as a susceptibility marker and estimate alcohol dependence-associated PPR rates of use, once use starts. In recent U.S. epidemiological samples, we identified 16,125 community-dwelling 12-to-20-year-olds with standardized assessments of both problem drinking and newly incident extra-medical PPR use. We applied zero-inflated Poisson (ZIP) regressions to estimate (a) alcohol dependence associations with susceptibility-to-persist after the very first occasion of extra-medical PPR use, and (b) the rate of PPR use, conditional on persistence. Underage drinkers with alcohol dependence were more susceptible to persistence in their extra-medical PPR use (p < .001). In addition, given susceptibility-to-persistence, there was an alcohol dependence-associated excess rate of extra-medical PPR use (risk ratio = 1.3; 95% confidence interval = 1.1, 1.6). Using ZIP regressions, we can see that underage alcohol dependence signals membership in a susceptible-to-persistence class of extra-medical PPR users and excess rates of extra-medical use. Underage drinking can be an indicator of greater vulnerability to start and persist in extra-medical use of PPR, particularly if presenting clinical features of alcohol dependence already are seen at or near time of first onset of such PPR use. For alcohol dependence-affected adolescent patients, nondrug pain management plans deserve consideration, with special surveillance if analgesic drugs are prescribed. Implications for genetic susceptibility research are discussed. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Citing Articles

Female-male differences in prescription pain reliever dependence levels: Evidence on newly incident adolescent and young adult users in the United States, 2002-2014.

Cheng H, Parker M, Anthony J Drug Alcohol Depend. 2019; 204:107466.

PMID: 31518887 PMC: 6878123. DOI: 10.1016/j.drugalcdep.2019.05.006.

Persistence of extra-medical prescription pain reliever use and alcohol involvement among United States 12-20 year olds.

Parker M Exp Clin Psychopharmacol. 2019; 27(5):502-509.

PMID: 30869981 PMC: 6785979. DOI: 10.1037/pha0000262.

References

Mullahy J . Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998; 17(3):247-81. DOI: 10.1016/s0167-6296(98)00030-7. View

Wagner F, Anthony J . Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol. 2002; 155(10):918-25. DOI: 10.1093/aje/155.10.918. View

Lasagna L, VON FELSINGER J, BEECHER H . Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. J Am Med Assoc. 1955; 157(12):1006-20. DOI: 10.1001/jama.1955.02950290026009. View

Sung H, Richter L, Vaughan R, Johnson P, Thom B . Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates. J Adolesc Health. 2005; 37(1):44-51. DOI: 10.1016/j.jadohealth.2005.02.013. View

Schepis T, Krishnan-Sarin S . Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry. 2008; 47(7):745-754. PMC: 3695621. DOI: 10.1097/CHI.0b013e318172ef0ld. View

Martins S, Storr C, Zhu H, Chilcoat H . Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2008; 99(1-3):58-67. PMC: 2650824. DOI: 10.1016/j.drugalcdep.2008.06.013. View

Chou R, Fanciullo G, Fine P, Adler J, Ballantyne J, Davies P . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2):113-30. PMC: 4043401. DOI: 10.1016/j.jpain.2008.10.008. View

Barondess D, Meyer E, Boinapally P, Fairman B, Anthony J . Epidemiological evidence on count processes in the formation of tobacco dependence. Nicotine Tob Res. 2010; 12(7):734-41. PMC: 2902880. DOI: 10.1093/ntr/ntq073. View

Meier E, Troost J, Anthony J . Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: national estimates by age and by year. Arch Pediatr Adolesc Med. 2012; 166(9):803-7. PMC: 4346252. DOI: 10.1001/archpediatrics.2012.209. View

10.

Seedall R, Anthony J . Risk estimates for starting tobacco, alcohol, and other drug use in the United States: male-female differences and the possibility that 'limiting time with friends' is protective. Drug Alcohol Depend. 2013; 133(2):751-3. PMC: 4388029. DOI: 10.1016/j.drugalcdep.2013.06.035. View

11.

Jones C, Paulozzi L, Mack K . Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. JAMA Intern Med. 2014; 174(5):802-3. PMC: 6688495. DOI: 10.1001/jamainternmed.2013.12809. View

12.

Seedall R, Anthony J . Monitoring by Parents and Hypothesized Male-Female Differences in Evidence from a Nationally Representative Cohort Re-sampled from Age 12 to 17 Years: An Exploratory Study Using a "Mutoscope" Approach. Prev Sci. 2014; 16(5):696-706. PMC: 4452596. DOI: 10.1007/s11121-014-0517-8. View

13.

Veliz P, Epstein-Ngo Q, Austic E, Boyd C, McCabe S . Opioid use among interscholastic sports participants: an exploratory study from a sample of college students. Res Q Exerc Sport. 2014; 86(2):205-11. PMC: 4430342. DOI: 10.1080/02701367.2014.983219. View

14.

Reyes-Gibby C, Yuan C, Wang J, Yeung S, Shete S . Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. BMC Syst Biol. 2015; 9:25. PMC: 4456775. DOI: 10.1186/s12918-015-0167-x. View

15.

Vsevolozhskaya O, Anthony J . Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology. Neuropsychopharmacology. 2015; 41(3):869-76. PMC: 4707832. DOI: 10.1038/npp.2015.213. View

16.

Parker M, Anthony J . Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12-21 year olds in the United States using meta-analysis, 2002-13. PeerJ. 2015; 3:e1340. PMC: 4662579. DOI: 10.7717/peerj.1340. View

17.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016; 65(1):1-49. DOI: 10.15585/mmwr.rr6501e1. View

18.

Yamaguchi K, Kandel D . Patterns of drug use from adolescence to young adulthood: II. Sequences of progression. Am J Public Health. 1984; 74(7):668-72. PMC: 1651663. DOI: 10.2105/ajph.74.7.668. View

19.

Yamaguchi K, Kandel D . Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am J Public Health. 1984; 74(7):673-81. PMC: 1651671. DOI: 10.2105/ajph.74.7.673. View